AbbVie snaps eight straight sessions of losses
AbbVie (ABBV) shares snapped eight consecutive sessions of losses as the stock closed up XYZ% at $XYZ. The North ...
AbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings
AbbVie (ABBV) reports Q3 earnings Wednesday. The acquisition of Aliada Therapeutics may boost its Alzheimer's portfolio and ...
Forbes8d
AbbVie Makes Notable Cross Below Critical Moving Average
In trading on Monday, shares of AbbVie crossed below their 200 day moving average of $178.81, changing hands as low as $172.70 per share. AbbVie Inc shares are currently trading down about 12.4% ...
Seeking Alpha28d
AbbVie: Strong Dividends But Humira Disappoints
Valuation metrics show AbbVie to be only slightly undervalued based on FY 2025 projections. With Humira revenue degrading, it would be wise to wait for evidence of a revenue replacement before ...